Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - Adamas Pharmaceuticals Inc | a2223253zex-31_2.htm |
| EX-31.1 - EX-31.1 - Adamas Pharmaceuticals Inc | a2223253zex-31_1.htm |
| EX-32.1 - EX-32.1 - Adamas Pharmaceuticals Inc | a2223253zex-32_1.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Adamas Pharmaceuticals Inc | Financial_Report.xls |
| XML - IDEA: XBRL DOCUMENT - Adamas Pharmaceuticals Inc | R9999.htm |
| 10-K - 10-K - Adamas Pharmaceuticals Inc | a2223253z10-k.htm |
QuickLinks -- Click here to rapidly navigate through this document
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-195384) of Adamas Pharmaceuticals, Inc. of our report dated March 3, 2015 relating to the financial statements of Adamas Pharmaceuticals, Inc., which appears in this Form 10-K for the year ended December 31, 2014.
/s/ PricewaterhouseCoopers LLP
San
Jose, California
March 3, 2015
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM